Rigel Pharma (RIGL) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $39.04 +0.90%
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q2 EPS of ($0.16), $0.01 worse than the analyst estimate of ($0.15).
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
- DA Davidson flags Duolingo DAU momentum stalling, keeps Neutral at $120
- Gorilla Technology raises Q2 2026 revenue outlook to $44M
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
